An Open-Label, Phase 1 Study to Examine the Pharmacokinetic Interactions Between VX-509 and Prednisone or Methylprednisolone in Healthy Male Subjects
Phase of Trial: Phase I
Latest Information Update: 13 Aug 2013
Price : $35 *
At a glance
- Drugs Decernotinib (Primary) ; Methylprednisolone; Prednisone
- Indications Rheumatoid arthritis
- Focus Pharmacokinetics
- Sponsors Vertex Pharmaceuticals
- 01 Aug 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 25 Jul 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 03 Jul 2013 New trial record